A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition
W.A. Macdonald(Monash University), James McCluskey(Peter Doherty Institute), Lars Kjer‐Nielsen(The University of Melbourne), David Williams, Craig S. Clements(University of Colorado Anschutz Medical Campus), Andrëw G. Brööks(The University of Melbourne), Nicole A. Mifsud(The University of Melbourne), Lauren K. Ely(Howard Hughes Medical Institute), Scott R. Burrows(Australian National University), Jamie Rossjohn(Institute of Infection and Immunity), Rhonda Holdsworth(Australian Red Cross Lifeblood), Anthony W. Purcell(Discovery Institute), Louis Lu(CSIRO Manufacturing), Brian D. Tait(Australian Red Cross Lifeblood), George O. Lovrecz(Health Sciences and Nutrition), Jeffrey J. Gorman(QIMR Berghofer Medical Research Institute), David M. Koelle(Infectious Disease Research Institute)
Cited by 209
Related Papers
More than one reason to rethink the use of peptides in vaccine design
|Nature Reviews Drug Discovery|2007|860
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis
|The Journal of Experimental Medicine|1998|713
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
|The Journal of Experimental Medicine|2013|595